Search
Search Results
##search.searchResults.foundPlural##
-
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2237PDF: 1220HTML: 3884 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2947PDF: 1388HTML: 3583Untitled: 202Untitled: 215Untitled: 190 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1058PDF: 560HTML: 7820 -
-
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1149PDF: 553HTML: 1702Figures: 179Fifures Sanz: 186tables Sanz: 188Untitled: 185 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2335PDF: 1347HTML: 17104Bassan Fig.1: 153Bassan Fig.2: 168Bassan Fig.4: 145Fig.3: 213 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4598PDF: 1955HTML: 17860 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3309PDF: 1731HTML: 1103 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2800PDF: 996HTML: 624 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3151PDF: 927HTML: 2085 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1712PDF: 1267HTML: 359 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1516PDF: 801Suppl. Files: 337Html: 141 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4479PDF: 1659HTML: 4082Tables and Images: 246 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1622PDF: 644HTML: 479 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4467PDF: 1538HTML: 1564Untitled: 243 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3755PDF: 1642HTML: 83 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2846PDF: 1850HTML: 3690Pellagatti Fig 1: 226Pellagatti Fig. 2: 219 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2863PDF: 1034HTML: 5531 -
-
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1234PDF: 611HTML: 6806 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2585PDF: 863HTML: 8918Efremov 1: 242Efremov 2: 207 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2035PDF: 827HTML: 229 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2879PDF: 1114HTML: 126 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3359PDF: 1268HTML: 2216 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1517PDF: 928HTML: 2219Response to reviewers comments: 195







